Özet:

The new type of coronavirus disease 2019, which was declared a pandemic in March 2020 [coronavirus disease-2019 (COVID-19)], is mainly observed by the signs and findings of the respiratory system. The receptor of angiotensin conversion enzyme, which is the input receptor of the severe acute respiratory syndrome-coronavirus-2 virus, has a widespread tissue distribution in the body. Therefore, in the disease the signs of the respiratory system and the findings, as well as the symptoms and findings related to other systems, can be monitored. In literature, the most frequently muscle-skeletal effects seen along with COVID-19 include arthritis, myalgia, fatigue and muscle weakness; neurological effects tables include cerebrovascular events, headaches, sensation of turmoil, awareness disorders, epilepsy, ataksi, acute dysemine encephalomyelitis, viral encephalitis, smell and/or taste loss or loss and clinical tables seen with other cranio nerve positions and Guillain-Barré syndrome. Since COVID-19 patients with non-specific or light respiratory system complaints at the beginning of the disease can apply to symptoms and findings of musculoskeletal and nervous system, including arthralgia and myalgia, which are common in physical medicine and rehabilitation practice, this symptom and findings may also appear before the symptoms and findings of the respiratory system monitored in COVID-19, it is important to keep COVID-19 in mind in the detailed diagnosis. In this disease, which seems to be quite infectious, it is important for patients to contribute to the earlier diagnosis and isolation.

Anahtar Kelimeler: